Ishares Genomics Immunology Etf Market Value
| IDNA Etf | USD 24.08 0.53 2.15% |
| Symbol | IShares |
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IShares Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IShares Genomics' etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IShares Genomics.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in IShares Genomics on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding iShares Genomics Immunology or generate 0.0% return on investment in IShares Genomics over 30 days. IShares Genomics is related to or competes with Global X, IShares Cybersecurity, and IShares Self. The fund generally will invest at least 80 percent of its assets in the component securities of the index and in investm... More
IShares Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IShares Genomics' etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iShares Genomics Immunology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 6.2 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 1.74 |
IShares Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IShares Genomics' standard deviation. In reality, there are many statistical measures that can use IShares Genomics historical prices to predict the future IShares Genomics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.06) |
iShares Genomics Imm Backtested Returns
iShares Genomics Imm holds Efficiency (Sharpe) Ratio of -0.0062, which attests that the entity had a -0.0062% return per unit of risk over the last 3 months. iShares Genomics Imm exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Genomics' Market Risk Adjusted Performance of (0.05), risk adjusted performance of (0.03), and Standard Deviation of 1.23 to validate the risk estimate we provide. The etf retains a Market Volatility (i.e., Beta) of 1.01, which attests to a somewhat significant risk relative to the market. IShares Genomics returns are very sensitive to returns on the market. As the market goes up or down, IShares Genomics is expected to follow.
Auto-correlation | -0.21 |
Weak reverse predictability
iShares Genomics Immunology has weak reverse predictability. Overlapping area represents the amount of predictability between IShares Genomics time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iShares Genomics Imm price movement. The serial correlation of -0.21 indicates that over 21.0% of current IShares Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
iShares Genomics Imm lagged returns against current returns
Autocorrelation, which is IShares Genomics etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IShares Genomics' etf expected returns. We can calculate the autocorrelation of IShares Genomics returns to help us make a trade decision. For example, suppose you find that IShares Genomics has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IShares Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IShares Genomics etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IShares Genomics etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IShares Genomics etf over time.
Current vs Lagged Prices |
| Timeline |
IShares Genomics Lagged Returns
When evaluating IShares Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IShares Genomics etf have on its future price. IShares Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IShares Genomics autocorrelation shows the relationship between IShares Genomics etf current value and its past values and can show if there is a momentum factor associated with investing in iShares Genomics Immunology.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Genomics Imm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Genomics Immunology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Genomics Immunology Etf:Check out IShares Genomics Correlation, IShares Genomics Volatility and IShares Genomics Alpha and Beta module to complement your research on IShares Genomics. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
IShares Genomics technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.